Robert A - Search Results

1

[Evaluation of the automated coagulation analyser ACL TOP (instrumentation laboratory)].

Eschwège V, Catillon C, Robert A. Eschwège V, et al. Among authors: robert a. Ann Biol Clin (Paris). 2006 May-Jun;64(3):259-64. Ann Biol Clin (Paris). 2006. PMID: 16698562 Free article. Clinical Trial. French.

2

Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway.

Robert A, Eschwège V, Hameg H, Drouet L, Aillaud MF. Robert A, et al. Thromb Haemost. 1996 Apr;75(4):562-6. Thromb Haemost. 1996. PMID: 8743179

3

The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level.

Eschwège V, Seddiki S, Robert A. Eschwège V, et al. Among authors: robert a. Thromb Haemost. 1996 Jul;76(1):65-8. Thromb Haemost. 1996. PMID: 8819253 Clinical Trial.

4

Screening for identified and unidentified protein C pathway defects by the Agkistrodon contortrix venom test in consecutive patients.

Robert A, Aillaud MF, Eschwège V, Verdy E, Barthet MC, Morange PE, Juhan-Vague I. Robert A, et al. Am J Clin Pathol. 1999 Aug;112(2):233-7. doi: 10.1093/ajcp/112.2.233. Am J Clin Pathol. 1999. PMID: 10439804 Clinical Trial.

5

Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.

d'Audigier C, Delassasseigne C, Robert A, Eschwège V. d'Audigier C, et al. Among authors: robert a. Int J Lab Hematol. 2016 Feb;38(1):50-3. doi: 10.1111/ijlh.12434. Epub 2015 Sep 25. Int J Lab Hematol. 2016. PMID: 26406495

6

Strikes in French public transport and resistance to activated protein C.

Eschwège V, Robert A. Eschwège V, et al. Among authors: robert a. Lancet. 1996 Jan 20;347(8995):206. doi: 10.1016/s0140-6736(96)90393-1. Lancet. 1996. PMID: 8544587 No abstract available.

7

ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden.

Robert A, Aillaud MF, Eschwège V, Randrianjohany A, Scarabin Y, Juhan-Vague I. Robert A, et al. Thromb Haemost. 2000 Apr;83(4):630-1. Thromb Haemost. 2000. PMID: 10780330 No abstract available.

8

Control of oral anticoagulation in patients with the antiphospholipid syndrome--influence of the lupus anticoagulant on International Normalized Ratio. Groupe Méthodologie en Hémostase du Groupe d'Etudes sur l'Hémostases et la Thrombose.

Robert A, Le Querrec A, Delahousse B, Caron C, Houbouyan L, Boutière B, Horellou MH, Reber G, Sié P. Robert A, et al. Thromb Haemost. 1998 Jul;80(1):99-103. Thromb Haemost. 1998. PMID: 9684793 Clinical Trial.

9

Two different incubation times for the activated partial thromboplastin time (APTT): a new criterion for diagnosis of lupus anticoagulant.

Robert A. Robert A. Thromb Haemost. 1994 Feb;71(2):220-4. Thromb Haemost. 1994. PMID: 8191402

10

Influence of age, sex and ABO blood group on activated partial thromboplastin time.

Fourel V, Gabastou JM, Desroys du Roure F, Ehrhardt N, Robert A. Fourel V, et al. Among authors: robert a. Haemostasis. 1993 Nov-Dec;23(6):321-6. doi: 10.1159/000216895. Haemostasis. 1993. PMID: 8034238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,604 results

Search Page

Filters